亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Randomized, Double-Blind, Placebo-Controlled Phase II Study of Yeast-Brachyury Vaccine (GI-6301) in Combination with Standard-of-Care Radiotherapy in Locally Advanced, Unresectable Chordoma

医学 安慰剂 临床终点 短尾鱼 内科学 脊索瘤 危险系数 胃肠病学 肿瘤科 置信区间 随机对照试验 免疫学 外科 病理 生物 胚胎干细胞 基因 替代医学 中胚层 生物化学
作者
Peter J. DeMaria,Marijo Bilušić,Deric M. Park,Christopher R. Heery,Renee N. Donahue,Ravi A. Madan,Mohammad Hadi Bagheri,Julius Strauss,Victoria Shen,Jennifer L. Marté,Seth M. Steinberg,Jeffrey Schlom,Mark R. Gilbert,James L. Gulley
出处
期刊:Oncologist [AlphaMed Press]
卷期号:26 (5): e847-e858 被引量:37
标识
DOI:10.1002/onco.13720
摘要

Brachyury is a transcription factor overexpressed in chordoma and is associated with chemotherapy resistance and epithelial-to-mesenchymal transition. GI-6301 is a recombinant, heat-killed Saccharomyces cerevisiae yeast-based vaccine targeting brachyury. A previous phase I trial of GI-6301 demonstrated a signal of clinical activity in chordomas. This trial evaluated synergistic effects of GI-6301 vaccine plus radiation.Adults with locally advanced, unresectable chordoma were treated on a randomized, placebo-controlled trial. Patients received three doses of GI-6301 (80 × 107 yeast cells) or placebo followed by radiation, followed by continued vaccine or placebo until progression. Primary endpoint was overall response rate, defined as a complete response (CR) or partial response (PR) in the irradiated tumor site at 24 months. Immune assays were conducted to evaluate immunogenicity.Between May 2015 and September 2019, 24 patients enrolled on the first randomized phase II study in chordoma. There was one PR in each arm; no CRs were observed. Median progressive-free survival for vaccine and placebo arms was 20.6 months (95% confidence interval [CI], 5.7-37.5 months) and 25.9 months (95% CI, 9.2-30.8 months), respectively. Hazard ratio was 1.02 (95% CI, 0.38-2.71). Vaccine was well tolerated with no vaccine-related serious adverse events. Preexisting brachyury-specific T cells were detected in most patients in both arms. Most patients developed T-cell responses during therapy, with no difference between arms in frequency or magnitude of response.No difference in overall response rate was observed, leading to early discontinuation of this trial due to low conditional power to detect statistical difference at the planned end of accrual.Chordoma is a rare neoplasm lacking effective systemic therapies for advanced, unresectable disease. Lack of clinically actionable somatic mutations in chordoma makes development of targeted therapy quite challenging. While the combination of yeast-brachyury vaccine (GI-6301) and standard radiation therapy did not demonstrate synergistic antitumor effects, brachyury still remains a good target for developmental therapeutics in chordoma. Patients and their oncologists should consider early referral to centers with expertise in chordoma (or sarcoma) and encourage participation in clinical trials.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
共享精神应助ceeray23采纳,获得20
刚刚
Lendar完成签到 ,获得积分10
2秒前
5秒前
明亮猫咪发布了新的文献求助10
11秒前
炙热的夜雪完成签到 ,获得积分10
12秒前
Jasper应助hehehehe采纳,获得10
16秒前
Lucas应助完美的流沙采纳,获得10
16秒前
22秒前
小太阳完成签到,获得积分10
23秒前
27秒前
30秒前
草上飞完成签到 ,获得积分10
32秒前
hehehehe发布了新的文献求助10
35秒前
35秒前
hehehehe完成签到,获得积分10
44秒前
ffff完成签到 ,获得积分10
58秒前
yingying发布了新的文献求助10
1分钟前
量子星尘发布了新的文献求助10
1分钟前
canan发布了新的文献求助10
1分钟前
1分钟前
kajikaji完成签到,获得积分10
1分钟前
江姜酱先生完成签到,获得积分10
1分钟前
1分钟前
咕咕风发布了新的文献求助10
1分钟前
咕咕风完成签到,获得积分20
1分钟前
脑洞疼应助lf采纳,获得30
1分钟前
科研通AI5应助忧伤的风华采纳,获得10
1分钟前
flow完成签到,获得积分10
1分钟前
1分钟前
lf发布了新的文献求助30
1分钟前
苗条的小蜜蜂完成签到 ,获得积分10
1分钟前
orixero应助科研通管家采纳,获得30
2分钟前
2分钟前
2分钟前
2分钟前
2分钟前
2分钟前
2分钟前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3976619
求助须知:如何正确求助?哪些是违规求助? 3520720
关于积分的说明 11204567
捐赠科研通 3257359
什么是DOI,文献DOI怎么找? 1798716
邀请新用户注册赠送积分活动 877897
科研通“疑难数据库(出版商)”最低求助积分说明 806613